External Validation of the eCura System for Undifferentiated-Type Early Gastric Cancer with Noncurative Endoscopic Resection

作者
Hyo‐Joon Yang,Young‐Il Kim,Ji Yong Ahn,Kee Don Choi,Sang Gyun Kim,Seong Woo Jeon,Jie‐Hyun Kim,Sung Kwan Shin,Hyuk Lee,Wan‐Sik Lee,Gwang Ha Kim,Jae Myung Park,Woon Geon Shin,Il Ju Choi
出处
期刊:Gut and Liver [Korean Association for the Study of the Liver]
卷期号:17 (4): 537-546 被引量:19
标识
DOI:10.5009/gnl220333
摘要

Background/Aims: The eCura system, a scoring model for stratifying the lymph node metastasis risk after noncurative endoscopic resection for early gastric cancer (EGC), has been internally validated, primarily for differentiated-type EGC. We aimed to externally validate this model for undifferentiated-type EGC. Methods: This multicenter, retrospective cohort study included 634 patients who underwent additional surgery (radical surgery group, n=270) or were followed up without additional treatment (no additional treatment group, n=364) after noncurative endoscopic resection for undifferentiated-type EGC between 2005 and 2015. The lymph node metastasis and survival rates were compared according to the risk categories. Results: For the radical surgery group, the lymph node metastasis rates were 2.6%, 10.9%, and 14.8% for the low-, intermediate-, and high-risk eCura categories, respectively (p for trend=0.003). For the low-, intermediate-, and high-risk categories in the no additional treatment group, the overall survival (92.7%, 68.9%, and 80.0% at 5 years, respectively, p<0.001) and cancer-specific survival rates (99.7%, 94.7%, and 80.0% at 5 years, respectively, p<0.001) differed significantly. In the multivariate analysis, the hazard ratios (95% confidence interval) in the no additional treatment group relative to the radical surgery group were 3.18 (1.41 to 7.17; p=0.005) for overall mortality and 2.60 (0.46 to 14.66; p=0.280) for cancer-specific mortality in the intermediate-to-high risk category. No such differences were noted in the low-risk category. Conclusions: The eCura system can be applied to undifferentiated-type EGC. Close follow-up without additional treatment might be considered for low-risk patients, while additional surgery is recommended for intermediate- and high-risk patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zsfzuiishuai发布了新的文献求助10
刚刚
芒果凤梨气泡美式的应助被guan采纳,获得10
刚刚
win发布了新的文献求助10
刚刚
刚刚
zdd完成签到,获得积分10
1秒前
鱼鱼完成签到,获得积分10
1秒前
1秒前
赘婿的应助被能干的长颈鹿采纳,获得10
1秒前
1秒前
xixi发布了新的文献求助20
2秒前
2秒前
WUDI发布了新的文献求助30
2秒前
2秒前
程烁发布了新的文献求助10
2秒前
幽默的夏寒完成签到,获得积分10
2秒前
keyan完成签到,获得积分20
2秒前
3秒前
乐乐的应助被水晶撞地球采纳,获得10
3秒前
跳跃煎蛋发布了新的文献求助10
3秒前
sunhealth完成签到,获得积分10
3秒前
Aline完成签到,获得积分10
3秒前
li发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
余香的应助被欧小猫采纳,获得10
5秒前
hhud发布了新的文献求助10
6秒前
Up发布了新的文献求助10
6秒前
月落星沉发布了新的文献求助10
6秒前
6秒前
尼可深蓝完成签到 ,获得积分10
6秒前
7秒前
桐桐的应助被JCSY采纳,获得10
7秒前
马志海发布了新的文献求助10
7秒前
彭于晏的应助被马騳骉采纳,获得10
7秒前
李健的应助被czh351采纳,获得10
8秒前
8秒前
molihuakai的应助被幽默的夏寒采纳,获得10
8秒前
8秒前
西溪完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153389
求助须知:如何正确求助?哪些是违规求助? 9550014
关于积分的说明 21696271
捐赠科研通 7741851
什么是DOI,文献DOI怎么找? 3425440
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469123